Compare CDZI & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CDZI | BNTC |
|---|---|---|
| Founded | 1983 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Supply | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 444.6M | 405.7M |
| IPO Year | N/A | N/A |
| Metric | CDZI | BNTC |
|---|---|---|
| Price | $5.25 | $10.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $27.67 |
| AVG Volume (30 Days) | ★ 925.0K | 119.4K |
| Earning Date | 03-27-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $15,979,000.00 | N/A |
| Revenue This Year | $58.18 | N/A |
| Revenue Next Year | $32.89 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 188.33 | N/A |
| 52 Week Low | $2.13 | $9.70 |
| 52 Week High | $6.96 | $17.15 |
| Indicator | CDZI | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 46.82 | 33.28 |
| Support Level | $4.69 | $11.45 |
| Resistance Level | $5.09 | $12.88 |
| Average True Range (ATR) | 0.38 | 0.69 |
| MACD | -0.04 | -0.18 |
| Stochastic Oscillator | 38.06 | 18.15 |
Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, which derives key revenue, and comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, which provides water filtration solutions for impaired or contaminated groundwater sources.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.